Jennifer Schmidt

Director of Preclinical Research & Development at Transcend Therapeutics

Jennifer brings over 25 years of neuroscience research experience from MIT (B.S.), Yale (Ph.D.) and the Rockefeller University (post-doctoral fellowship), where she worked closely with Ron Duman - who proposed the neurotrophic hypothesis of antidepressant activity- and Nobel Laureate Paul Greengard, studying neuropsychiatric diseases at molecular, cellular and behavioral levels. Prior to joining Transcend, Jennifer was the Director of R&D at Magnolia Neurosciences.

Links

Previous companies

Rockefeller University logo
Yale University logo
Magnolia Neurosciences logo
New York University logo
Aptinyx logo
Harvard University logo
McLean Hospital logo

Timeline

  • Director of Preclinical Research & Development

    February, 2022 - present